Sign in

Georg Winter

@georgwinter.bsky.social
1.3K followers 190 following 23 posts

Chemical Biologist with passion for Cancer Research, Targeted Protein Degradation & Transcription.Scientific Founder of Proxygen & Solgate. Pats Fan. Dad. winter-lab.com

PostsRepliesMedia
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 30/06/2026
Congratulations to @georgwinter.bsky.social, AITHYRA Life Science Director and CeMM Adjunct PI, on being elected as Member of the European Molecular Biology Organization (EMBO), one of the highest honors in the Life Sciences. www.embo.org/press-releas... #EMBOmember2026
photo credit: Natascha Unkart
191
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 26/03/2026
AITHYRA is recruiting an AI/ML STARTING PI Generative Models, Large Language Models, Agentic AI, Active & Reinforcement Learning, AI-driven Scientific Discovery & Lab Automation, ML-driven molecular simulations... Job Ad: aithyra.at/fileadmin/do... Apply by 30.4.2026 #StartingPI #AI/ML #AITHYRA
11513
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 26/03/2026
AITHYRA is recruiting a LIFE SCIENCE PI We are interested in research questions related to one of our four core disease areas: cancer research, immunological disorders, infectious diseases, neurodevelopment disorders. Job Ad: aithyra.at/fileadmin/do... Apply by 30.4.2026 #StartingPI #LS #AITHYRA
0813
Reposted by Georg Winter
MPI Dortmund @mpi-dortmund.bsky.social · 08/01/2026
paper alert🚨 Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3 - Published by the groups of Herbert Waldmann @waldido.bsky.social , Slava Ziegler and @georgwinter.bsky.social @cemm.oeaw.ac.at in @nature.com Chemistry www.nature.com/articles/s41...
nature.com
Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3 - Nature Chemistry
In targeted protein degradation, a degrader molecule brings a neosubstrate protein proximal to a hijacked E3 ligase for its ubiquitination. Here, pseudo-natural products derived from (−)-myrtanol—iDeg...
085
Reposted by Georg Winter
Silvia Ramundo @sramundo.bsky.social · 15/01/2026
Flagging a cool funding opportunity closing soon: AITHYRA Global Collaborator! $150k/year to tackle AI × biomedicine grand challenges. Shame there’s no plant science angle—but we’ll forgive them for now 😉! @georgwinter.bsky.social @mmbronstein.bsky.social @aithyra.bsky.social
aithyra.bsky.social
AITHYRA Research Institute of the Austrian Academy of Sciences (@aithyra.bsky.social)
AITHYRA is a new dynamic research institute for biomedical AI in Vienna. AITHYRA seeks to build Europe’s premier institute for AI-driven biological and medical research, uniting computer scientists, e...
083
Georg Winter @georgwinter.bsky.social · 11/12/2025
congrats, Alex
020
Reposted by Georg Winter
nataliescholes.bsky.social @nataliescholes.bsky.social · 27/11/2025
Excited to share our work on inhibitors turning degraders now out: doi.org/10.1038/s415...
doi.org
Inhibitors supercharge kinase turnover through native proteolytic circuits - Nature
Inhibitor-induced kinase degradation is a common event that positions supercharging of endogenous degradation circuits as an alternative to classical proximity-inducing degraders.
1296
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 26/11/2025
New Study published in Nature by the group of @georgwinter.bsky.social, From Inhibition to Destruction - Kinase Drugs Found to Trigger Protein Degradation aithyra.at/news/ #AITHYRA #CeMM #TPD
Georg Winter and first author Natalie Scholes (c) Barbara Bachmann/CeMM
0176
Reposted by Georg Winter
Mikko Taipale @miketilapia.bsky.social · 19/11/2025
We are looking for a postdoctoral fellow to work on induced proximity 🤜🤛 and functional genomics! Join our team in Toronto 🇨🇦 to tackle major challenges in oncology and neurodegeneration. www.nature.com/naturecareer...
nature.com
POSTDOCTORAL FELLOW - Toronto (City), Ontario (CA) job with Taipale Lab, Donnelly Centre, University of Toronto | 12849004
The Taipale lab in the Donnelly CCBR and University of Toronto is looking for a highly motivated Postdoctoral Fellow
03244
Reposted by Georg Winter
Cigall Kadoch @ckadoch.bsky.social · 12/09/2025
Was wonderful presenting at the #AITHYRA AI for Life Science Opening Symposium in Vienna this week! Thank you @mmbronstein.bsky.social and @georgwinter.bsky.social for the invitation to present our newest work! #biology #research #AIforLifeScience @imbavienna.bsky.social @francesarnold.bsky.social
3183
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 08/09/2025
We are honored that Nobel laureate @francesarnold.bsky.social of @caltech.edu is giving the keynote lecture tonight at the #AIforLifeScience Symposium!
092
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 10/09/2025
“We need to start all over again and reinvent small molecule drug discovery in a way that is native to AI”, Greg Verdine, Co-Founder, President and CEO of LifeMine Therapeutics, is convinced. #AIForLifeScience #AITHYRA
052
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 10/09/2025
“We can do science in a different way: generate very big datasets, train models with them, and then use that to predict and engineer biology”, says @benlehner.bsky.social from @sangerinstitute.bsky.social at the #AITHYRA #AIForLifeScience Symposium
062
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 10/09/2025
Everything comes to an end, but we have the feeling that the first AITHYRA #AIinLifeScience Symposium in Vienna can only be the beginning of a conference series. Thanks to all participants for a successful event! www.oeaw.ac.at/aithyra/about
AITHYRA #AIinLifeScience Symposium Participants (c) Bubu Dujmic
0111
Reposted by Georg Winter
CeMM @cemm.oeaw.ac.at · 10/09/2025
🎉 Celebrating 5 years of CeMM #SpinOffs Proxygen & Solgate! From molecular glue degraders to solute carriers, both companies show how basic research can drive #biotech innovation & have a real impact for patients. 🔎 Learn more about their scientific journey & research: bit.ly/4pdIl7N
092
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 29/08/2025
With great pleasure we announce that XINYI ZHANG is one of the Starting PIs AI/LS who will join AITHYRA. Xinyi will develop machine learning models for cell and tissue biology: from multimodal integration to biomarkers and function. More info: www.oeaw.ac.at/aithyra/rese... #AITHYRA #StartingPI
Xinyi Zhang = curious + adventurous + collaborative + nature-loving + pilot
0204
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 25/07/2025
Apply for the AITHYRA-CeMM International PhD Program! 15-20 fully funded PhD fellowships available in Vienna, AT in AI/ML and Life Sciences Deadline for applications: 10 September 2025 apply.cemm.at
01510
Reposted by Georg Winter
Michael Bronstein @mmbronstein.bsky.social · 24/07/2025
@aithyra.bsky.social Opening Symposium "AI for Life Science" with Nobel Laureate Frances Arnold as keynote speaker in addition to an outstanding line up of speakers on a variety of topics across biological scales and data modalities. Registration is now open at cemm.at/aithyra-symp...
1188
Reposted by Georg Winter
Heather Harrington @haharrington.bsky.social · 26/06/2025
We are searching for an AI researcher in lab automation, statistical ML and (theoretical) physics AI for bio/med. Expression of interest and nominations welcome!!!
033
Reposted by Georg Winter
CeMM @cemm.oeaw.ac.at · 12/05/2025
New #EquationsForLife at #CeMM! Discover how the @georgwinter.bsky.social's lab pioneers #TDP. By modeling interactions between degraders & binding partners, their chosen #HillEquation helps them optimize degrader design to eliminate disease-relevant proteins precisely. 🔎 tinyurl.com/CeMMRR2024-W...
062
Reposted by Georg Winter
Alexander Hanzl @alexanderhanzl.bsky.social · 08/05/2025
- Mutations mimicking glues by @brianliau.bsky.social al and Ning Zheng - Covalent and bivalent glue engagement by @dannomura.bsky.social, Nathanael Gray, @georgwinter.bsky.social and @alessiociulli.bsky.social - And finish it of with a discussion on general mode-of-action.
193
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 02/05/2025
Thank you to many Starting PI candidates who showed their interest in joining #AITHYRA. We will need a few weeks to go over the applications with our hiring committee, but will come back to you asap. The PI hearing is planned to take place in Vienna, mid of June. 👐
Happy AITHYRA Directors Anita Ender, Michael Bronstein and Georg Winter with an optimistic view into the future (c) Natascha Unkart.jpg
093
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 02/05/2025
Please save-the-date for the #AITHYRA Symposium “AI for Life Science”, which will take place in Vienna at the House of Industry from 8-10 September 2025. Great speakers, interesting framework programme and beautiful location. Registration will open mid May. More info: www.oeaw.ac.at/aithyra/news...
13313
Reposted by Georg Winter
Michael Bronstein @mmbronstein.bsky.social · 03/05/2025
Join us in Vienna on Sep 8-10 with an incredible speaker lineup!
1247
Reposted by Georg Winter
Michael Bronstein @mmbronstein.bsky.social · 29/04/2025
A reminder that @aithyra.bsky.social has an open call for starting PIs. We offer some of the best conditions in Europe rivalling MP and ETHZ www.oeaw.ac.at/aithyra/news...
oeaw.ac.at
Search for LIFE SCIENCE and AI/ML Starting Principal Investigators (m/f/d) at AITHYRA, Vienna
If you are an ambitious early-career scientist ready to propel your research to new heights, we invite you to be part of AITHYRA’s founding generation of Principal Investigators. Together, we will sha...
1316
Reposted by Georg Winter
Jacob Schreiber @jmschreiber91.bsky.social · 29/04/2025
Deadline is tomorrow!
071
Reposted by Georg Winter
Nature Reviews Cancer @natrevcancer.nature.com · 28/04/2025
REVIEW 🚨 Targeted protein degradation (TPD) is an emerging pharmacological modality in cancer therapy. Here, Winter + colleagues, outline the mechanistic bases of TPD and outline both established + upcoming classes of degraders. 📖 👇
bit.ly
Targeted protein degradation for cancer therapy - Nature Reviews Cancer
Targeted protein degradation (TPD) is an emerging pharmacological modality in cancer therapy. In this Review, Hinterndorfer et al. outline the mechanistic bases of TPD and discuss the characteristics, advantages and applications of established compounds as well as upcoming classes of degraders.
0115
Reposted by Georg Winter
AITHYRA Research Institute of the Austrian Academy of Sciences @aithyra.bsky.social · 28/04/2025
Please welcome AITHYRA, the Research Institute for Artificial Intelligence of the Austrian Academy of Science on social media. Follow us and connect via Bluesky and LinkedIn 👋
0175
Georg Winter @georgwinter.bsky.social · 28/04/2025
Hello, we are AITHYRA! I am very excited to share with you the corporate identity of AITHYRA, the Research Institute for Biomedical AI. Check out the brand design video (sound on!) to learn more. **REMINDER** One week left to apply for Starting PI positions (Life Science and AI/ML). Come join us!
0208
Georg Winter @georgwinter.bsky.social · 07/04/2025
🚨 Hiring Alert – Senior Scientist (Biology) 🚨 My lab is looking for a senior scientist to lead functional genomics efforts and decode how small molecules reshape biology 🧬 Lead screens 🤝 Collaborate with top-tier AI/chemistry/biology minds Interested? then apply: cemm.onlyfy.jobs/job/t7lhh1kz
oeaw.ac.at
AITHYRA
0149
Reposted by Georg Winter
Michael Bronstein @mmbronstein.bsky.social · 17/03/2025
Aithyra is hiring! We are looking for multiple starting PIs in life sciences and AI/ML. We offer highly competitive packages and salaries among the highest in Europe. www.oeaw.ac.at/aithyra/news...
oeaw.ac.at
Search for LIFE SCIENCE and AI/ML Starting Principal Investigators (m/f/d) at AITHYRA, Vienna
If you are an ambitious early-career scientist ready to propel your research to new heights, we invite you to be part of AITHYRA’s founding generation of Principal Investigators. Together, we will sha...
23912
Georg Winter @georgwinter.bsky.social · 13/03/2025
Something that qualifies as big news from my side: I am very happy and excited to announce that I have been appointed as Life Science Director at AITHYRA, a new Research Institute for Biomedical Artificial Intelligence. Find out more in the link and 🧵 below lnkd.in/d_HaGuSE
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
310611
Georg Winter @georgwinter.bsky.social · 30/01/2025
Excited about programming biology via induced proximity? Then mark June 2026 in your calendar and consider participating in the GRC Conference on Induced Proximity Modalities and Therapeutics that I am co-organizing with @danetteldaniels.bsky.social tinyurl.com/brtuffam
0217
Georg Winter @georgwinter.bsky.social · 08/01/2025
this is exciting!
030
Reposted by Georg Winter
Clausen Lab @clausenlab.bsky.social · 21/12/2024
🎄 xmas preprint 🎄 we are excited to share our cryo-EM structure of UBR4 in complex with KCMF1 and CALM1. the PQC ligase forms a massive ubiquitination arena, primed to amplify ubiquitin chains (E4 activity) and boost degradation of defective proteins. www.biorxiv.org/content/10.1...
Architecture of the 1.3 MDa complex of human UBR4 (2 x UBR4/KCMF1/CALM1). Picture shows top and side views of the cryo-EM density map and the modeled structure, colored by protein components and domains.
313338
Georg Winter @georgwinter.bsky.social · 03/12/2024
We are very grateful for the ERC Consolidator Grant awarded to my research group! Through our interest in TPD, we have developed expertise in proximity induction which we now leverage to directly rewire transcriptional circuits dysregulated or mutated in cancer. cemm.at/news/n/erc-c...
cemm.at
ERC Consolidator Grant Propels Georg Winter’s Groundbreaking Work
11746
Reposted by Georg Winter
SFB Targeted Protein Degradation @sfb-tpd-vienna.bsky.social · 29/11/2024
SAVE THE DATE 🗓️Ubiquitin & Friends Symposium: 8-9 May 2025 in Vienna! Registration will open🔜 Keep an eye out for the announcement 👀 ✨guest speaker lineup👇🧵 +talks from abstracts! Great chance for #ECRs to meet with peers & experts in a friendly setting! 🔗 www.protein-degradation.org/symposium/
15928
Reposted by Georg Winter
Olivier Saulnier @olivier-saulnier.bsky.social · 24/11/2024
Let's build a starter pack for childhood cancer research. Please send a message to be added! 🎗️ go.bsky.app/Tpd9QnM
2913827
Reposted by Georg Winter
Stephan Hacker @stephanhacker2.bsky.social · 28/11/2024
My "Scientists to Follow" Starter Pack has reached its capacity of 150. Some really exciting additions including @verhelstlab.bsky.social, @supertifurgalab.bsky.social, @georgwinter.bsky.social, @kusterlab.bsky.social, @kimmb1.bsky.social and @katyavinogradova.bsky.social go.bsky.app/3SyoVNw
03212
Georg Winter @georgwinter.bsky.social · 28/11/2024
Dual-ligase PROTACs: a novel approach for enhancing TPD. By recruiting two distinct E3 ligases within a single molecule, we amplify degradation efficacy & potentially mitigate resistance occurrence. Great collabo with the Ciulli lab & friends at Promega. pubs.acs.org/doi/10.1021/...
pubs.acs.org
Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera
Proteolysis targeting chimera (PROTAC) degraders are typically bifunctional with one E3 ligase ligand connected to one target protein ligand via a linker. While augmented valency has been shown with trivalent PROTACs targeting two binding sites within a given target protein, or used to recruit two different targets, the possibility of recruiting two different E3 ligases within the same compound has not been demonstrated. Here we present dual-ligase recruitment as a strategy to enhance targeted protein degradation. We designed heterotrivalent PROTACs composed of CRBN, VHL and BET targeting ligands, separately tethered via a branched trifunctional linker. Structure–activity relationships of 12 analogues qualifies AB3067 as the most potent and fastest degrader of BET proteins, with minimal E3 ligase cross-degradation. Comparative kinetic analyses in wild-type and ligase single and double knockout cell lines revealed that protein ubiquitination and degradation induced by AB3067 was contributed to by both CRBN and VHL in an additive fashion. We further expand the scope of the dual-ligase approach by developing a heterotrivalent CRBN/VHL-based BromoTag degrader and a tetravalent PROTAC comprising of two BET ligand moieties. In summary, we provide proof-of-concept for dual-E3 ligase recruitment as a strategy to boost degradation fitness by recruiting two E3 ligases with a single degrader molecule. This approach could potentially delay the outset of resistance mechanisms involving loss of E3 ligase functionality.
14711
Georg Winter @georgwinter.bsky.social · 27/11/2024
I had the chance to see this amazing story presented recently and I'd strongly recommend to read the Nature paper by our friends in the Obenauf lab @obenaufa.bsky.social Congratulations to all involved!!
090
Reposted by Georg Winter
Rune Busk Damgaard @rbdamgaard.bsky.social · 15/11/2024
Check out this list of ubiquitin and Ubl profiles to follow. Repost if you want me to add you to it. Let’s create a good community here ☁️ go.bsky.app/3VPQofn
64848